US healthcare spending in 2024 jumped 7.2% to $5.3 trillion, driven by rising insurance enrolment, service use, and administrative costs.
You must be a subscriber to access all of this content.
Aspen Pharmacare business sale boosts investor confidence. A strategic pivot following a turbulent 2025 rebuilds financial flexibility.
You must be a subscriber to access all of this content.
Hospital-acquired infections remain untracked nationally, risking thousands of preventable deaths and silent outbreaks in public hospitals.
You must be a subscriber to access all of this content.
Discovery Health claims will now be covered by the scheme after a processing error led to member outcry and regulatory scrutiny.
You must be a subscriber to access all of this content.
European drug pricing dispute heats up as pharma giants demand higher returns after US price cuts. Tensions are on the rise.
You must be a subscriber to access all of this content.